An 8-month-old infant with hypercalcemia and hyperphosphatemia—Answers

This is a preview of subscription content, log in to check access.

Fig. 1

References

  1. 1.

    Leung J, Crook M (2019) Disorders of phosphate metabolism. J Clin Pathol 72:741–747

    CAS  Article  Google Scholar 

  2. 2.

    Carfagna F, Del Vecchio L, Pontoriero G, Locatelli F (2018) Current and potential treatment options for hyperphosphatemia. Expert Opin Drug Saf 17:597–607

    CAS  Article  Google Scholar 

  3. 3.

    Messa P, Alfieri CM (2018) Secondary and tertiary hyperparathyroidism. Front Horm Res 51:91–108. https://doi.org/10.1159/000491041

    CAS  Article  PubMed  Google Scholar 

  4. 4.

    Whyte MP (2017) Hypophosphatasia: an overview for 2017. Bone 102:15–25. https://doi.org/10.1016/j.bone.2017.02.011

    CAS  Article  PubMed  Google Scholar 

  5. 5.

    Di Rocco F, Baujat G, Cormier-Daire V, Rothenbuhler A, Linglart A (2017) Craniosynostosis and hypophosphatasia. Arch Pediatr 24:5S89–5S92. https://doi.org/10.1016/S0929-693X(18)30022-8

  6. 6.

    Taketani T, Onigata K, Kobayashi H, Mushimoto Y, Fukuda S, Yamaguchi S (2014) Clinical and genetic aspects of hypophosphatasia in Japanese patients. Arch Dis Child 99:211–215. https://doi.org/10.1136/archdischild-2013-305037

  7. 7.

    Whyte MP, Greenberg CR, Salman NJ, Bober MB, McAlister WH, Wenkert D, Van Sickle BJ, Simmons JH, Edgar TS, Bauer ML, Hamdan MA, Bishop N, Lutz RE, McGinn M, Craig S, Moore JN, Taylor JW, Cleveland RH, Cranley WR, Lim R, Thacher TD, Mayhew JE, Downs M, Millán JL, Skrinar AM, Crine P, Landy H (2012) Enzyme-replacement therapy in life-threatening hypophosphatasia. N Engl J Med 366:904–913. https://doi.org/10.1056/NEJMoa1106173

  8. 8.

    Whyte MP, Simmons JH, Moseley S, Fujita KP, Bishop N, Salman NJ, Taylor J, Phillips D, McGinn M, McAlister WH (2019) Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial. Lancet Diabetes Endocrinol 7:93–105. https://doi.org/10.1016/S2213-8587(18)30307-3

  9. 9.

    Kishnani PS, Rush ET, Arundel P, Bishop N, Dahir K, Fraser W, Harmatz P, Linglart A, Munns CF, Nunes ME, Saal HM, Seefried L, Ozono K (2017) Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa. Mol Genet Metab 122(1–2):4–17. https://doi.org/10.1016/j.ymgme.2017.07.010

  10. 10.

    Whyte MP (2017) Hypophosphatasia: an overview for 2017. Bone. 102:15–25. https://doi.org/10.1016/j.bone.2017.02.011

    CAS  Article  PubMed  Google Scholar 

  11. 11.

    Whyte MP, Zhang F, Wenkert D, McAlister WH, Mack KE, Benigno MC, Coburn SP, Wagy S, Griffin DM, Ericson KL, Mumm S (2015) Hypophosphatasia: validation and expansion of the clinical nosology for children from 25years experience with 173 pediatric patients. Bone 75:229–239. https://doi.org/10.1016/j.bone.2015.02.022

  12. 12.

    Sağlam H, Erdöl Ş, Dorum S (2017) Clinical and genetic findings of Turkish hypophosphatasia cases. JCRPE J Clin Res Pediatr Endocrinol 9:229–236. https://doi.org/10.4274/jcrpe.4549

    Article  PubMed  Google Scholar 

  13. 13.

    Baujat G, Michot C, Le Quan Sang KH, Cormier-Daire V (2017) Perinatal and infantile hypophosphatasia: clinical features and treatment. Arch Pediatr 24:5S61–5S65. https://doi.org/10.1016/S0929-693X(18)30016-2

    CAS  Article  PubMed  Google Scholar 

  14. 14.

    Bacchetta J (2017) Renal impairment in hypophosphatasia. Arch Pediatr 24:5S93–5S95. https://doi.org/10.1016/S0929-693X(18)30023-X

    CAS  Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Mehmet Taşdemir.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Statement of honorarium, grant, or other form of payment to another person for manuscript preparation

The authors stated that the manuscript is of their original work and no one except the authors included into the preparation of the manuscript.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This refers to the article that can be found at http://dx.doi.org/10.1007/s00467-020-04656-7.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Özler, O., Mutlu, G.Y., Taşdemir, M. et al. An 8-month-old infant with hypercalcemia and hyperphosphatemia—Answers. Pediatr Nephrol (2020). https://doi.org/10.1007/s00467-020-04666-5

Download citation

Keywords

  • Chronic kidney disease
  • Infant
  • Low alkaline phosphatase